CDK2-IN-57
CDK2-IN-57 is a selective Cdk2/CycE inhibitor with an IC50 of 2.8 nM. CDK2-IN-57 inhibits Cdk1/2 kinase activity, blocks cell cycle progression, induces G0-phase cell cycle arrest, and prevents S-phase entry. CDK2-IN-57 can be used for the research of colon carcinoma.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C22H30N4O4
- Masse moléculaire:414.50
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
|
CDK2/Cyc E 2.8 nM (IC50) |
CDK2-IN-57 (Compound 22) potently inhibits the purified Cdk2/CycE complex with an IC50 of 2.8 nM[1].
CDK2-IN-57 (20 nM-100 μM; 48 h) induces dose-responsive cell cycle arrest at G0 and reduced viability in HCT-116 colon cancer cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HCT-116 colon cancer cells
-
Concentration:20 nM; 50 nM; 100 nM; 200 nM; 390 nM; 780 nM; 1.56 μM; 3.13 μM; 6.25 μM; 12.5 μM; 25 μM; 50 μM; 100 μM
-
Incubation Time:48 h
-
Result:Reduced cell number of cells positive for Edu and pHH3 in a dose-dependent manner.
Induces dose-responsive cell cycle arrest at G0 and reduced viability.
Chemical Information
-
Masse moléculaire 414.50
-
Formule C22H30N4O4
-
SMILES
O=C(CC1=CC=C(C=C1)OC)NC2=NNC([C@H]3CC[C@@H](OC(N(C)C(C)C)=O)C3)=C2
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
CDK2-IN-57 Related Classifications
HY-183146 Related Classifications
Powered by Bioz